Kymera Therapeutics Inc. Common Stock vs Park Hotels & Resorts Inc. Common Stock — how do they compare? Kymera Therapeutics Inc. Common Stock trades at $106.9 (market cap $8.87B), while Park Hotels & Resorts Inc. Common Stock trades at $15.12 (market cap $3.14B). The key difference: Kymera Therapeutics Inc. Common Stock is far larger — about 2.8× Park Hotels & Resorts Inc. Common Stock's market cap, and Park Hotels & Resorts Inc. Common Stock pays a 6.41% dividend while Kymera Therapeutics Inc. Common Stock pays none. Which is the better fit depends on your goals — on Pluang, investors hold Kymera Therapeutics Inc. Common Stock for 0 Days and Park Hotels & Resorts Inc. Common Stock for 0 Days on average.
| KYMR | PK | |
|---|---|---|
Market Cap | $8.87B | $3.14B |
Volume | 779,107 | 3,553,985 |
Sector | Health | Real Estate |
52-Week High | $127.31 | $16.17 |
52-Week Low | $55.80 | $9.84 |
Typical Hold Time | 0 Days | 0 Days |
Enterprise Value | $8.26B | $6.98B |
Dividend Yield | — | 6.41% |
Trailing returns across standard periods
What Pluang investors did over the last 30 days
Kymera Therapeutics, Inc. is a biopharmaceutical company developing small-molecule medicines based on targeted protein degradation, using its Pegasus platform to direct the body's natural protein-disposal system against disease-causing proteins.
Read more on KYMR →Park Hotels & Resorts Inc. is a US lodging REIT, spun off from Hilton Worldwide in 2017, that owns a portfolio of premium-branded hotels and resorts in major urban, resort, and convention markets.
Read more on PK →